Compositional Characterization of Glassy Volcanic Material From VSWIR and MIR Spectra Using Partial Least Squares Regression Models.

Autor: Leight, C. J.¹ (AUTHOR) cleight@utk.edu, Ytsma, C.² (AUTHOR), McCanta, M. C.¹ (AUTHOR), Dyar, M. D.^3,4 (AUTHOR), Glotch, T. D.⁵ (AUTHOR)

Publikováno v: Earth & Space Science. Jun2024, Vol. 11 Issue 6, p1-22. 22p.

Disease coverage of human genome-wide association studies and pharmaceutical research and development.

Autor: Gordillo-Marañón M; Institute of Cardiovascular Science, Faculty of Population Health, University College London, London, United Kingdom. maria.maranon.16@ucl.ac.uk., Schmidt AF; Institute of Cardiovascular Science, Faculty of Population Health, University College London, London, United Kingdom.; Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands.; UCL British Heart Foundation Research Accelerator, London, United Kingdom., Warwick A; Institute of Cardiovascular Science, Faculty of Population Health, University College London, London, United Kingdom., Tomlinson C; Institute of Health Informatics, Faculty of Population Health, University College London, London, United Kingdom., Ytsma C; Institute of Health Informatics, Faculty of Population Health, University College London, London, United Kingdom., Engmann J; Institute of Cardiovascular Science, Faculty of Population Health, University College London, London, United Kingdom., Torralbo A; Institute of Health Informatics, Faculty of Population Health, University College London, London, United Kingdom., Maclean R; Institute of Health Informatics, Faculty of Population Health, University College London, London, United Kingdom., Sofat R; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom.; Health Data Research, London, United Kingdom., Langenberg C; Precision Healthcare University Research Institute, Queen Mary University of London, London, United Kingdom.; Computational Medicine, Berlin Institute of Health at Charité Universitätsmedizin, Berlin, Germany.; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom., Shah AD; Institute of Health Informatics, Faculty of Population Health, University College London, London, United Kingdom.; NIHR Biomedical Research Centre at University College London Hospitals, London, United Kingdom., Denaxas S; Institute of Health Informatics, Faculty of Population Health, University College London, London, United Kingdom.; NIHR Biomedical Research Centre at University College London Hospitals, London, United Kingdom.; British Heart Foundation Data Science Centre, London, United Kingdom., Pirmohamed M; Department of Pharmacology and Therapeutics, Centre for Drug Safety Science, University of Liverpool, Liverpool, United Kingdom., Hemingway H; Institute of Health Informatics, Faculty of Population Health, University College London, London, United Kingdom.; Health Data Research, London, United Kingdom.; NIHR Biomedical Research Centre at University College London Hospitals, London, United Kingdom., Hingorani AD; Institute of Cardiovascular Science, Faculty of Population Health, University College London, London, United Kingdom.; UCL British Heart Foundation Research Accelerator, London, United Kingdom., Finan C; Institute of Cardiovascular Science, Faculty of Population Health, University College London, London, United Kingdom.; UCL British Heart Foundation Research Accelerator, London, United Kingdom.

Publikováno v: Communications medicine [Commun Med (Lond)] 2024 Oct 08; Vol. 4 (1), pp. 195. Date of Electronic Publication: 2024 Oct 08.

Proteomic signatures improve risk prediction for common and rare diseases.

Autor: Carrasco-Zanini J; Human Genetics and Genomics, GSK Research and Development, Stevenage, UK. j.carrasco-zanini-sanchez@qmul.ac.uk.; MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge, Cambridge, UK. j.carrasco-zanini-sanchez@qmul.ac.uk.; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK. j.carrasco-zanini-sanchez@qmul.ac.uk.; Computational Medicine, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany. j.carrasco-zanini-sanchez@qmul.ac.uk., Pietzner M; MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK.; Computational Medicine, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany., Davitte J; Human Genetics and Genomics, GSK Research and Development, Collegeville, PA, USA., Surendran P; Human Genetics and Genomics, GSK Research and Development, Stevenage, UK., Croteau-Chonka DC; Human Genetics and Genomics, GSK Research and Development, Cambridge, MA, USA., Robins C; Human Genetics and Genomics, GSK Research and Development, Collegeville, PA, USA., Torralbo A; Institute of Health Informatics, University College London, London, UK., Tomlinson C; Institute of Health Informatics, University College London, London, UK.; National Institute for Health Research, Biomedical Research Centre, University College London Hospitals NHS Trust, London, UK., Grünschläger F; Heidelberg Institute for Stem Cell Technology and Experimental Medicine, Heidelberg, Germany.; Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Fitzpatrick N; Institute of Health Informatics, University College London, London, UK., Ytsma C; Institute of Health Informatics, University College London, London, UK., Kanno T; Human Genetics and Genomics, GSK Research and Development, Collegeville, PA, USA., Gade S; Genomic Sciences, Cellzome GmbH, GSK Research and Development, Heidelberg, Germany., Freitag D; Human Genetics and Genomics, GSK Research and Development, Stevenage, UK., Ziebell F; Genomic Sciences, Cellzome GmbH, GSK Research and Development, Heidelberg, Germany., Haas S; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK.; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.; Charité-Universitätsmedizin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Denaxas S; Institute of Health Informatics, University College London, London, UK.; National Institute for Health Research, Biomedical Research Centre, University College London Hospitals NHS Trust, London, UK.; Health Data Research UK, London, UK.; British Heart Foundation Data Science Centre, London, UK., Betts JC; Human Genetics and Genomics, GSK Research and Development, Stevenage, UK., Wareham NJ; MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge, Cambridge, UK., Hemingway H; Institute of Health Informatics, University College London, London, UK.; National Institute for Health Research, Biomedical Research Centre, University College London Hospitals NHS Trust, London, UK.; Health Data Research UK, London, UK., Scott RA; Human Genetics and Genomics, GSK Research and Development, Stevenage, UK. robert.a.scott@gsk.com., Langenberg C; MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge, Cambridge, UK. claudia.langenberg@qmul.ac.uk.; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK. claudia.langenberg@qmul.ac.uk.; Computational Medicine, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany. claudia.langenberg@qmul.ac.uk.

Publikováno v: Nature medicine [Nat Med] 2024 Sep; Vol. 30 (9), pp. 2489-2498. Date of Electronic Publication: 2024 Jul 22.

Cognitive Impairment and Dementia in Atrial Fibrillation: A Population Study of 4.3 Million Individuals.

Autor: Chung SC, Rossor M, Torralbo A, Ytsma C, Fitzpatrick NK, Denaxas S, Providencia R

Publikováno v: JACC. Advances [JACC Adv] 2023 Oct 25; Vol. 2 (9), pp. 100655. Date of Electronic Publication: 2023 Oct 25 (Print Publication: 2023).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.